May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat

Cannabinoid Hyperemesis Syndrome

(2016) J. Andrew Woods et al.   AMERICAN JOURNAL OF THERAPEUTICS

Gastrointestinal dysfunction and enteric neurotoxicity following treatment with anticancer chemotherapeutic agent 5-fluorouracil

(2016) R. M. McQuade et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Toll-like receptors in the pathogenesis of chemotherapy-induced gastrointestinal toxicity

(2016) Elke Cario   Current Opinion in Supportive and Palliative Care

Dark Agouti rat model of chemotherapy-induced mucositis: Establishment and current state of the art

(2015) Barbara Vanhoecke et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Cannabis for Inflammatory Bowel Disease

(2014) Timna Naftali et al.   DIGESTIVE DISEASES

Toxicity of tandem high-dose chemotherapy and autologous stem cell transplantation using carboplatin-thiotepa-etoposide and cyclophosphamide-melphalan regimens for malignant brain tumors in children and young adults

(2014) Soo Hyun Lee et al.   JOURNAL OF NEURO-ONCOLOGY

The assessment of general well-being using spontaneous burrowing behaviour in a short-term model of chemotherapy-induced mucositis in the rat

(2014) A L Whittaker et al.   LABORATORY ANIMALS

Guidance on the management of diarrhoea during cancer chemotherapy

(2014) Jervoise Andreyev et al.   LANCET ONCOLOGY

Alleviating mucositis: are we on track for a novel therapeutic?

(2014) Rajesh V Lalla   Expert Review of Gastroenterology & Hepatology

X-ray analysis of the effect of the 5-HT3 receptor antagonist granisetron on gastrointestinal motility in rats repeatedly treated with the antitumoral drug cisplatin

(2014) Gema Vera et al.   EXPERIMENTAL BRAIN RESEARCH

Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability

(2013) B.S. Harvey et al.   CYTOKINE

Cannabinoids may worsen gastric dysmotility induced by chronic cisplatin in the rat

(2013) R. Abalo et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Effects of 5-Fluorouracil in Nuclear and Cellular Morphology, Proliferation, Cell Cycle, Apoptosis, Cytoskeletal and Caveolar Distribution in Primary Cultures of Smooth Muscle Cells

(2013) Marcelo de Carvalho Filgueiras et al.   PLoS One

Potential role of the NADPH oxidase NOX1 in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice

(2012) Masashi Yasuda et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

5-HT3receptor antagonists ameliorate 5-fluorouracil-induced intestinal mucositis by suppression of apoptosis in murine intestinal crypt cells

(2012) M Yasuda et al.   BRITISH JOURNAL OF PHARMACOLOGY

Protective role of μ opioid receptor activation in intestinal inflammation induced by mesenteric ischemia/reperfusion in mice

(2012) Francesca Saccani et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Effects of neo-adjuvant chemotherapy for oesophago-gastric cancer on neuro-muscular gastric function

(2012) E. Z. H. Sung et al.   MOLECULAR BIOLOGY REPORTS

The Gastrointestinal Pharmacology of Cannabinoids: Focus on Motility

(2012) Raquel Abalo et al.   PHARMACOLOGY

Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients With Nonconstipated Irritable Bowel Syndrome

(2011) Banny S. Wong et al.   GASTROENTEROLOGY

Enteric neuropathy evoked by repeated cisplatin in the rat

(2011) G. Vera et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors

(2011) R. Abalo et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Regulation of nausea and vomiting by cannabinoids

(2010) Linda A Parker et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT3 receptor antagonists

(2010) N. Percie du Sert et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat

(2010) R. Abalo et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Cisplatin-induced gastrointestinal dysmotility is aggravated after chronic administration in the rat. Comparison with pica

(2010) P. A. Cabezos et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Small Intestinal Cannabinoid Receptor Changes Following a Single Colonic Insult with Oil of Mustard in Mice

(2010) Edward S. Kimball et al.   Frontiers in Pharmacology

Gastrointestinal Microflora and Mucins May Play a Critical Role in the Development of 5-Fluorouracil-Induced Gastrointestinal Mucositis

(2009) Andrea M. Stringer et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Selective lack of tolerance to delayed gastric emptying after daily administration of WIN 55,212-2 in the rat

(2009) r. abalo et al.   NEUROGASTROENTEROLOGY AND MOTILITY

IL1β- and LPS-induced serotonin secretion is increased in EC cells derived from Crohn’s disease

(2009) m. kidd et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Review: Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management

(2009) Alexander Stein et al.   Therapeutic Advances in Medical Oncology

Radiological study of gastrointestinal motor activity after acute cisplatin in the rat. Temporal relationship with pica

(2008) Pablo Antonio Cabezos et al.   AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL

Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution

(2008) Pedro M. G. Soares et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB1receptors and fatty acid amide hydrolase

(2008) d. de filippis et al.   NEUROGASTROENTEROLOGY AND MOTILITY